Actively Recruiting
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
Led by University of Pittsburgh · Updated on 2026-05-07
300
Participants Needed
1
Research Sites
1051 weeks
Total Duration
On this page
Sponsors
U
University of Pittsburgh
Lead Sponsor
D
David Scaife Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The current study is a case control study involving comparisons of tissue interstitial fluid from breast cancer and adjacent non-cancerous tissue as well as that from benign breast lesion and its adjacent non-diseased tissue for a distinguishable breast cancer profile. The purpose of this research is to collect fresh breast nodule/cancer and surrounding non-cancerous tissue for proteomic studies of the interstitial fluid to identify a profile distinguishing breast cancer which will also permit future research on stored interstitial fluid, blood or tissue samples. Specific markers identified from interstitial fluid study will be investigated in blood samples to develop serum markers for breast cancer diagnosis and prognosis. Additionally, we will perform both prospective and retrospective research on breast cancer involving clinical, demographic, epidemiologic information, treatment, follow-up and outcomes on breast nodule/cancer cases collected.
CONDITIONS
Official Title
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants 18 years of age or older undergoing surgery for indeterminate breast nodules, breast tissue reduction, or prophylactic mastectomy
- Participants with newly diagnosed invasive breast cancer
- If invasive breast cancer or suspicion of invasive breast cancer, the target lesion must measure at least 1.0 cm on breast imaging before core biopsy
You will not qualify if you...
- Anyone younger than 18 years of age
- Participants with multiple synchronous primary malignancies from different organ systems
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UPMC St. Margaret
Pittsburgh, Pennsylvania, United States, 15215
Actively Recruiting
Research Team
L
Laura Chiesa
CONTACT
M
Min Sun, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here